0.08% 0.0005

AEON Biopharma Inc. (AEON)

Überblick Nachrichten Preisverlauf Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

AEON Biopharma Inc. Stock (AEON) Company Profile

AEON Biopharma Inc.

Healthcare (1176)

Biotechnology (673)

(949) 354-6499

5 Park Plaza, Suite 1750, Irvine

Nächster Verdiensttermin

Neueste SEC-Einreichungen

AEON's Discussions on Twitter

Vergleichen Sie AEON mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
AEON AEON Biopharma Inc.	0.65	25.98M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2023-08-18	Eingeleitet	H.C. Wainwright	Buy

AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten

Finanzdaten der AEON Biopharma Inc.-Aktie (AEON)

Es liegen keine Finanzdaten für AEON Biopharma Inc. (AEON) vor. Überprüfen Sie andere Aktien für weitere Informationen.

AEON Biopharma Inc. (AEON)

AEON Biopharma Inc. Stock (AEON) Company Profile

Vergleichen Sie AEON mit anderen Aktien

AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades

AEON Biopharma Inc. Aktie (AEON) Neueste Nachrichten

Head to Head Survey: AEON Biopharma (AEON) & Its Peers - Defense World

AEON Biopharma (AEON) vs. Its Peers Critical Survey - Defense World

Comparing AEON Biopharma (AEON) & Its Competitors - Defense World

Migraine Market Forecasted to Surge in Coming Years, 2023-2032 Analysis by DelveInsight | Amgen, Teva Pharma, Eli Lilly, Teva Pharma, Axsome Therapeutics, AEON Biopharma, Charleston Laboratories - Barchart

Blue Owl Capital Holdings LP Acquires New Stake in AEON Biopharm - GuruFocus.com

AEON Biopharma Reports Third Quarter 2024 Financial Results and Provides Corporate Update - The Manila Times

AEON Biopharma : Reports Third Quarter 2024 Financial Results and Provides Corporate Update Form 8 K - Marketscreener.com

AEON Biopharma Advances BOTOX Biosimilar Development, Secures FDA Meeting Milestone | AEON Stock News - StockTitan

Kailera Therapeutics Appoints Scott M. Akamine as Chief Legal Officer - GlobeNewswire

AEON Biopharma Inc. (AEON) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle

AEON Biopharma Releases New Investor Presentation - TipRanks

AEON Biopharma stock earns buy rating, holds price target on FDA meeting - Investing.com

AEON Biopharma maps FDA path for Botox biosimilar - Investing.com

AEON receives positive outcome in FDA biosimilar advisory meeting - MSN

AEON Biopharma Announces Positive Outcome from FDA Biosimilar Advisory Meeting - The Manila Times

AEON Biopharma (AMEX:AEON) Stock Quotes, Forecast and News Summary - Benzinga

AEON Biopharma, Inc. (AEON) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now - MSN

Trading Day Triumph: AEON Biopharma Inc. (AEON) Ends at 0.83, a -12.12 Surge/Plunge - The Dwinnex

AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024 - ForexTV.com

HC Wainwright Analysts Raise Earnings Estimates for AEON Biopharma, Inc. (NASDAQ:AEON) - Defense World

Vanguard Group Inc. Increases Position in AEON Biopharma, Inc. (NASDAQ:AEON) - Defense World

AEON Biopharma (NASDAQ:AEON) Given New $5.00 Price Target at HC Wainwright - Defense World

HC Wainwright Weighs in on AEON Biopharma, Inc.’s FY2028 Earnings (NASDAQ:AEON) - Defense World

H.C. Wainwright sees potential in AEON Biopharma stock despite funding uncertainties - Investing.com Canada

Midday Stock Roundup: Veritone Soars on NCAA Deal - Orange County Business Journal

AEON Stock Earnings: AEON Biopharma Beats EPS for Q2 2024 - InvestorPlace

AEON Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com

AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update - wallstreet:online

AEON Biopharma : Corporate Presentation - Marketscreener.com

AEON Biopharma Inc. (AEON) Stock: From Low to High in 52 Weeks - The InvestChronicle

AEON Biopharma Releases New Corporate Presentation - TipRanks

Ratio Analysis: Unpacking AEON Biopharma Inc. (AEON)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

AEON Biopharma (NASDAQ:AEON) Shares Down 11.8% - MarketBeat

Was there any good news for AEON Biopharma Inc. (AEON) stock in the last session? - US Post News

AEON Biopharma (NASDAQ:AEON) Trading Down 11.8% - Defense World

The Psychology of AEON Biopharma Inc. Inc. (AEON) Price Performance: Understanding Market Sentiment - The InvestChronicle

Insider’s View: Deciphering AEON Biopharma Inc. (AEON)’s Financial Health Through Ratios - The Dwinnex

Midday Stock Roundup: loanDepot Rises on Investor Hopes for Fed - Orange County Business Journal

Views of Wall Street’s Leading Experts on AEON Biopharma Inc. - SETE News

How to interpret AEON Biopharma Inc. (AEON)’s stock chart patterns - US Post News

AEON Biopharma Inc. (AEON) Stock: Navigating Market Highs and Lows in 52 Weeks - The InvestChronicle

Finanzdaten der AEON Biopharma Inc.-Aktie (AEON)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie AEON